Shares of Omeros Corporation (NASDAQ: OMER), a commercial-stage biopharmaceutical company, are on the move following the company's first-quarter earnings report. Although revenue fell off a cliff, investors liked what they heard …
Several months prior, the stock traded as high as $27.09. Nevertheless, it lost most value in the past three months, as shares depreciated over 25%. As alluded, Omeros has been on a rallied lately with 34% appreciation in the past 4 …
2018 Omeros issued the Lenders warrants to purchase an aggregate of 200,000 shares of Omeros common stock (the …
Omeros Corporation (NASDAQ: OMER) stock has been getting battered since its only marketed product stopped getting special treatment from an important government payer. Omidria's imminent decline is troubling, but perhaps the market …
If the stock closes at or above $10 at expiration this trade will return 13.37% or 18.15% (for comparison purposes only). OMER closed Apr 23, 2018's trading session at $14.42. In the past year, the stock has hit a 52-week low of $8.36 and …
If the stock closes at or above $10 at expiration this trade will return 12.10% or 21.66% (for comparison purposes only). OMER closed Apr 25, 2018's trading session at $13.72. In the past year, the stock has hit a 52-week low of $8.36 and …